MINNEAPOLIS 06/15/2017 — With a procedure performed today, the Minneapolis Heart Institute® at Abbott Northwestern Hospital became the third in the U.S. – following heart centers in Los Angeles and Phoenix – to perform 250 mitral heart valve repair procedures using a device called the MitraClip®. This procedure was live broadcasted for The 2017 Transcatheter Valve Therapies conference in Chicago, IL as a live case session.
MitraClip, made by Abbott Vascular in Santa Clara, Calif., is the only available minimally invasive option for people with a severe leak in the mitral valve who are too high-risk for traditional open heart surgery. This condition, called mitral regurgitation, is the most common heart valve disease.
“People who suffer from mitral regurgitation are among the most undertreated populations in the country. Less invasive treatment is a blessing for many patients who can’t tolerate open heart surgery,” said Paul Sorajja, M.D., Director, Center for Valve and Structural Disease director at Minneapolis Heart Institute® and Researcher at the Valve Science Center of Minneapolis Heart Institute Foundation®.
Dr. Sorajja recently completed a study examining the acute, 30-day and one-year outcomes of MitraClip that included about 3,000 patients in the U.S. That study found the procedure to be safe and effective in more than 90 percent of the patients treated. Dr. Sorajja presented those findins this past March in Washington, D.C. at The American College of Cardiology Annual Scientific Session & Expo.